| Dr Hla Win, MD | |
|
4501 Sand Creek Rd, Antioch, CA 94531-8687 | |
| (925) 813-3101 | |
| Not Available |
| Full Name | Dr Hla Win |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 26 Years |
| Location | 4501 Sand Creek Rd, Antioch, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629262647 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Permanente Medical Group Inc | 8921910225 | 7800 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
News outlets report on workforce issues, including the doctor shortage, Medicaid pay cuts and the effects of long work hours on medical residents.
Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 2 days ago
| Entity Name | Permanente Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073606299 PECOS PAC ID: 8921910225 Enrollment ID: O20031104000710 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
News outlets report on workforce issues, including the doctor shortage, Medicaid pay cuts and the effects of long work hours on medical residents.
Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Hla Win, MD 4501 Sand Creek Rd, Antioch, CA 94531-8687 Ph: (925) 813-3101 | Dr Hla Win, MD 4501 Sand Creek Rd, Antioch, CA 94531-8687 Ph: (925) 813-3101 |
News Archive
Scientists at the University of York have discovered that parasites responsible for leishmaniasis - a globally occurring neglected tropical disease spread by sand flies - are mainly acquired from the skin rather than a person's blood.
News outlets report on workforce issues, including the doctor shortage, Medicaid pay cuts and the effects of long work hours on medical residents.
Researchers at Penn Medicine have discovered that the tumor suppressor gene folliculin (FLCN) is essential to normal lung function in patients with the rare disease Birt-Hogg-Dube (BHD) syndrome, a genetic disorder that affects the lungs, skin and kidneys.
AVEO Pharmaceuticals, Inc., a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced preliminary results from an ongoing Phase 1b clinical trial evaluating the company's lead product candidate, tivozanib, a highly potent and selective inhibitor of VEGF receptors 1, 2, and 3, in combination with paclitaxel (Taxol®), a standard chemotherapy regimen, in patients with metastatic breast cancer.
› Verified 2 days ago
Chung M. Kung, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 5601 Deer Valley Rd, Antioch, CA 94531 Phone: 925-813-6500 | |
Prasad Pillai, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4721 Dallas Ranch Rd, Antioch, CA 94531 Phone: 925-778-0679 Fax: 925-778-3567 | |
Dr. Doris Sofia Galina-da Silva, DORIS GALINADA SILVA Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2370 Country Hills Dr Ste 101, Antioch, CA 94509 Phone: 925-779-9635 Fax: 925-779-9672 | |
Dr. Patricia Anne Yabut Haro, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 916-854-6975 Fax: 916-854-6844 | |
Dr. Kalyani Maganti, M.D. Endocrinology, Diabetes & Metabolism Medicare: May Accept Medicare Assignments Practice Location: 3903 Lone Tree Way, Suite 205, Antioch, CA 94509 Phone: 925-754-8710 Fax: 925-754-0765 | |
Al G. Sumaquial, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3400 Delta Fair Blvd, Antioch, CA 94509 Phone: 925-779-5000 | |
Veenu Goel Gupta, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 3901 Lone Tree Way, Antioch, CA 94509 Phone: 925-756-1192 |